Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Aug 6, 2025, after the close
10-Q filed Aug 7, 2025, 38 days after period end · 0000950170-25-104295
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $264.57M | $241.96M | $165.24M | $134.56M |
| Net Income | $26.67M | $33.39M | $1.11M | -$34.01M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| $0.16 |
| $0.20 |
| $0.01 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
